- Home
- MNOV vs STKS Comparison
MNOV vs STKS Comparison
Compare MNOV & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNOV | STKS |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.9M | 58.4M |
| IPO Year | 2004 | 2011 |
Fundamental Metrics
Financial Performance| Metric | MNOV | STKS |
|---|---|---|
| Price | $1.34 | $1.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $7.50 | $4.70 |
| AVG Volume (30 Days) | ★ 37.0K | 12.1K |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,360,807.00 | ★ $805,722,000.00 |
| Revenue This Year | N/A | $7.47 |
| Revenue Next Year | $180.00 | $8.12 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 194.15 | 19.66 |
| 52 Week Low | $1.17 | $1.65 |
| 52 Week High | $1.96 | $3.38 |
Technical Indicators
Market Signals| Indicator | MNOV | STKS |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 42.46 |
| Support Level | $1.24 | $1.71 |
| Resistance Level | $1.46 | $2.07 |
| Average True Range (ATR) | 0.04 | 0.11 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 6.67 | 7.66 |
Price Performance
Historical ComparisonAbout MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through three segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.